The death of a Scottish nurse as a result of complications after taking the drug Mounjaro for weight loss has highlighted the potential dangers ...

Novo Nordisk and Eli Lilly are racing to increase production in a weight-loss market estimated to reach at least $100 billion globally by the end of the decade. Both companies' obesity treatments ...

The company got approval to sell its tirzepatide injections—branded as Mounjaro—in a device called Kwikpen. Mounjaro is designed for long-term weight management and the treatment of type 2 ...

The agency has approved a four-dose version of the drug, called Mounjaro KwikPen, which provides a month’s course of GLP-1 and GIP agonist tirzepatide. Great Britain will be the first major ...

The company has received the Hong Kong government approval to sell its tirzepatide injections — branded as Mounjaro — in a ...

(Bloomberg) -- Eli Lilly & Co. expects to start selling its highly popular weight-loss drug in Hong Kong as early as the end of this year, potentially making it the first of its kind to become ...

We recently compiled a list of the Jim Cramer’s Latest Game Plan: 20 Stocks to Watch. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

INDIANAPOLIS, Oct. 30, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the third quarter of 2024. “Lilly had another strong growth quarter in Q3, with ...